ConductScience.org, home

Paper25908451

The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.

Boone BA and 10 others. Cancer Gene Ther, 2015. Cited by 154 papers, by iCite.

Cite this record

ConductScience Library. The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Papers, record 25908451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25908451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.
PubMed
Journal
Cancer Gene Ther
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
154
iCite
Relative citation ratio, by iCite
4.74
iCite
Revised in PubMed
2026-11-02
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boone BAB A
2Orlichenko LL
3Schapiro NEN E
4Loughran PP
5Gianfrate GCG C
6Ellis JTJ T
7Singhi ADA D
8Kang RR
9Tang DD
10Lotze MTM T
11Zeh HJH J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutophagyMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Extracellular TrapsMajor topic
NeutrophilsMajor topic
Pancreatic NeoplasmsMajor topic
Receptor for Advanced Glycation End ProductsMajor topic
Animals
Female
Humans
Mice
Mice, Knockout

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 CA113263NCI NIH HHSUnited StatesT32CA113263PubMed and NIHNIH RePORTER
T32CA113263NCI NIH HHSUnited StatesT32CA113263PubMed and NIHNIH RePORTER
P30CA047904NCI NIH HHSUnited StatesP30CA047904PubMed and NIHNIH RePORTER

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121698003Investigating the pathogenic role of PADI4 in oesophageal cancer.Int J Biol Sci2011https://conductscience.org/library/papers/21698003PubMed
218616529Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome.Cancer Sci2008https://conductscience.org/library/papers/18616529PubMed
323508552A proposed role for neutrophil extracellular traps in cancer immunoediting.Front Immunol2013https://conductscience.org/library/papers/23508552PubMed
424740698Neutrophil extracellular traps promote differentiation and function of fibroblasts.J Pathol2014https://conductscience.org/library/papers/24740698PubMed
520706768Protein arginine deiminase 4: a target for an epigenetic cancer therapy.Cell Mol Life Sci2011https://conductscience.org/library/papers/20706768PubMed
623316068HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.Am J Physiol Lung Cell Mol Physiol2013https://conductscience.org/library/papers/23316068PubMed
723722544Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis.Cancer Res2013https://conductscience.org/library/papers/23722544PubMed
824553385Detection of circulating tumor DNA in early- and late-stage human malignancies.Sci Transl Med2014https://conductscience.org/library/papers/24553385PubMed
921126167The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury.Antioxid Redox Signal2011https://conductscience.org/library/papers/21126167PubMed
1022052106RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.J Gastrointest Surg2012https://conductscience.org/library/papers/22052106PubMed
1122044575Neutrophil extracellular traps promote deep vein thrombosis in mice.J Thromb Haemost2012https://conductscience.org/library/papers/22044575PubMed
1220081861Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.Nat Med2010https://conductscience.org/library/papers/20081861PubMed
1324465790Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes.PLoS One2014https://conductscience.org/library/papers/24465790PubMed
1423227088Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase.Clin Dev Immunol2012https://conductscience.org/library/papers/23227088PubMed
1523110523Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.BMC Cancer2012https://conductscience.org/library/papers/23110523PubMed
1619834494The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival.Cell Death Differ2010https://conductscience.org/library/papers/19834494PubMed
1722703527Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.Cancer Sci2012https://conductscience.org/library/papers/22703527PubMed
1823308284The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest.PLoS One2013https://conductscience.org/library/papers/23308284PubMed
1922195044Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout.PLoS One2011https://conductscience.org/library/papers/22195044PubMed
2024449238Liquid biopsies: genotyping circulating tumor DNA.J Clin Oncol2014https://conductscience.org/library/papers/24449238PubMed

See all 64 referencesDownload CSV of references

Cited by119

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.

PMIDTitleJournalYearIn PapersSource
42732150Baseline Extracellular HMGB-1 Levels Associated with Induction Chemotherapy Response in Adult Acute Myeloid Leukemia.F1000Res2026https://conductscience.org/library/papers/42732150PubMed
42675156Neutrophil extracellular traps in tumor progression: from mechanistic insights and regulatory factors to clinical detection and diagnosis.J Mol Med (Berl)2026https://conductscience.org/library/papers/42675156PubMed
42596723Neutrophil-based immunotherapy: A metabolic lens on mechanisms and therapeutic implications.Clin Transl Med2026https://conductscience.org/library/papers/42596723PubMed
42485000Caught in the NET: A Review on the Emerging Role of Neutrophil Extracellular Traps in PDAC Development.Technol Cancer Res Treat2026https://conductscience.org/library/papers/42485000PubMed
42212337Neutrophil Extracellular Traps in Pancreatic Ductal Adenocarcinoma: A Vicious Cycle in the Tumor Microenvironment and Targeted Interventions.Int J Biol Sci2026https://conductscience.org/library/papers/42212337PubMed
42099651Neutrophil count and platelet-lymphocyte ratio as simple predictors of ustekinumab response in patients with Crohn's disease: a retrospective multicenter study.Front Immunol2026https://conductscience.org/library/papers/42099651PubMed
42023239Tumor-associated neutrophils in pancreatic ductal adenocarcinoma: mechanisms and therapeutic targeting.Front Immunol2026https://conductscience.org/library/papers/42023239PubMed
41981626Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade.Mol Cancer2026https://conductscience.org/library/papers/41981626PubMed
41827874Neutrophil Extracellular Traps in Exocrine Pancreatic Disease: A Comprehensive Review of Pathogenesis, Severity Stratification, and Therapeutic Targeting.Cells2026https://conductscience.org/library/papers/41827874PubMed
41736666PAF Triggered Pyroptotic NETosis Aggravates Myocardial Ischemia/Reperfusion Injury.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41736666PubMed
41648668Scavenger receptors: key players in the immunological puzzle of lupus.Front Lupus2025https://conductscience.org/library/papers/41648668PubMed
41617393Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.J Immunother Cancer2026https://conductscience.org/library/papers/41617393PubMed
41565749Application of group A streptococcal collagen-like protein 1-expressing Lactococcus as a novel immunotherapeutic against pancreatic ductal adenocarcinoma.Sci Rep2026https://conductscience.org/library/papers/41565749PubMed
41496500Multi-omics analysis identifies PUS7 as an immune modulator driving NETs-mediated macrophage polarization in pancreatic cancer.Clin Transl Med2026https://conductscience.org/library/papers/41496500PubMed
41411661Neutrophil extracellular trap inhibition revitalizes PDAC immunotherapy responsiveness via reduced fibrosis and TCF1+CD8+ progenitor T-cell expansion.Oncoimmunology2025https://conductscience.org/library/papers/41411661PubMed
41019086NETs - as predictors and targets of supportive therapy for cancer treatment.Front Immunol2025https://conductscience.org/library/papers/41019086PubMed
40805288Neutrophil Dynamics in Response to Cancer Therapies.Cancers (Basel)2025https://conductscience.org/library/papers/40805288PubMed
40797324Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition.J Inflamm (Lond)2025https://conductscience.org/library/papers/40797324PubMed
40742388Neutrophil Extracellular Traps Modulate Recruitment and Immunosuppression of Macrophages in Pancreatic Adenocarcinoma.Cancer Immunol Res2025https://conductscience.org/library/papers/40742388PubMed
40282474Role of Neutrophils in Anti-Tumor Activity: Characteristics and Mechanisms of Action.Cancers (Basel)2025https://conductscience.org/library/papers/40282474PubMed

See all 119 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGER177PubTator's text mininghttps://conductscience.org/library/genes/177NCBI Gene
ELANE1991PubTator's text mininghttps://conductscience.org/library/genes/1991NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
PADI423569PubTator's text mininghttps://conductscience.org/library/genes/23569NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25908451

GET https://conductscience.org/api/papers/v1/25908451/references?page=2